http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0143764-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_359b45ab51dbd97bd513b984a50c5ef0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0031 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 1984-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a003b1aa0704e5cb233e1c3cfb6a590 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c194db46a2a015bf7d9625c6d26f27a3 |
| publicationDate | 1985-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0143764-A1 |
| titleOfInvention | Novel androstane-17 beta-carboxylic acid esters, a process and intermediates for their preparation, composition and method for the treatment of inflammatory conditions |
| abstract | The invention refers to compounds having anti-inflammatory activity, characterized by the formulan in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents in the carbon atom at position 20, in which formula the 1, 2 position is saturated or is a double bond,n X, is hydrogen, fluorine, chlorine or bromine, X 2 is hydrogen, fluorine, chlorine or bromine, R, is hydrogen or methyl, R 2 is a straight or branched hydrocarbon chain having 1-10 carbon atoms and R, is hydrogen or a straight or branched chain alkyl group having 1-12 carbon atoms, a lower alkyl group substituted by 1-5 halogen atoms or an unsubstituted or substituted phenyl or benzyl group, provided that when R, is methyl R 2 is a hydrocarbon chain having 2-10 carbon atoms. n The invention also refers to a process and intermediates for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment of inflammatory conditions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197761-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0934745-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6423340-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5643602-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0197018-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6432967-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9724365-A1 |
| priorityDate | 1983-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.